Clinical Nutrition Market Report 2025-2033: Global Forecast by Product, Applications, and End Users

The global Clinical Nutrition Market size reached USD 55.8 Billion in 2024. It is projected to grow to USD 104.6 Billion by 2033, exhibiting a CAGR of 7.2% during the forecast period 2025-2033. Growth is driven by the rising prevalence of chronic diseases, aging populations, increased awareness of nutrition in healthcare, innovations in personalized nutrition, and changing dietary habits.

Study Assumption Years

Base Year: 2024
Historical Year/Period: 2019-2024
Forecast Year/Period: 2025-2033

Clinical Nutrition Market Key Takeaways

Current Market Size: USD 55.8 Billion in 2024
CAGR: 7.2% during 2025-2033
Forecast Period: 2025-2033

Key drivers include growing collaborations between market players and increased adoption of functional food products.
The rising geriatric population and technological advancements in healthcare are prominent trends.
Asia Pacific holds the largest market share due to the high prevalence of chronic diseases.
Major challenges include regulatory hurdles and costs of specialized nutritional products.
Opportunities lie in personalized nutrition and integration of digital health technologies.

Sample Request Link:
https://www.imarcgroup.com/clinical-nutrition-market/requestsample

Market Growth Factors

The global clinical nutrition market is driven by increased collaborations among key industry players. This cooperative approach helps accelerate the introduction of innovative nutritional products and functional foods, which meet growing consumer demand. The adoption of functional food products significantly contributes to the market's growth, as these products cater to improving health outcomes and managing chronic diseases.

The rising geriatric population worldwide is a substantial growth factor. The elderly often face poor nutrient absorption and slowed metabolism, necessitating clinical nutrition interventions to manage chronic illnesses such as diabetes, cancer, osteoporosis, and cardiovascular disorders. According to the World Health Organization (WHO), the population aged 80+ is expected to triple by 2050, reaching 426 million, which further fuels market demand.

Advancements in technology like nutrigenomics, metabolomics, wearable devices, smartphone apps, and digital health platforms support personalized nutrition solutions. These innovations enable real-time feedback, remote monitoring, and customized health management, fostering a proactive approach toward nutritional health. Additionally, changing dietary patterns and lifestyle habits, including sedentary behavior and irregular meals, increase risks of malnutrition and metabolic disorders, thereby boosting demand for tailored clinical nutrition interventions.

Market Segmentation

By Product:

Infant Nutrition: Addresses newborns' and infants' dietary needs with nutrients, bioactive substances, and antibodies.
Parental Nutrition: Not provided in source.
Enteral Nutrition: Not provided in source.

By Route of Administration:

Oral: The largest segment includes dietary supplements, functional foods, OTC pharmaceuticals, and oral nutritional supplements in various formats.
Enteral: Not provided in source.
Parenteral: Not provided in source.

By Application:

Cancer: Clinical nutrition supports cancer patients by addressing appetite loss, nausea, and metabolic changes due to treatments.
Malnutrition: Addresses nutrient deficiencies, weight loss, and immune impairment caused by diverse medical conditions.
Metabolic Disorders: Manages energy metabolism abnormalities through dietary optimization.
Gastrointestinal Disorders: Not provided in source.
Neurological Disorders: Not provided in source.
Others: Not provided in source.

By End User:

Pediatric: The dominant segment, which focuses on nutritional needs during growth and development.
Adults: Not provided in source.
Geriatric: Addresses poor nutrient absorption and chronic illness management among the elderly.

By Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Regional Insights

Asia Pacific dominates the clinical nutrition market, holding the largest market share. Growth is propelled by rapid urbanization, changing dietary habits, and an increasing burden of chronic diseases. Rising income levels and expanding healthcare access further stimulate demand. The aging population, especially in India and China, also contributes significantly, with the population aged 80+ in India forecasted to grow 279% between 2022 and 2050.

Recent Developments & News

On 16 February 2023, Nestlé Health Science and EraCal Therapeutics Ltd. launched a research collaboration to identify new nutraceuticals for controlling food intake, merging Nestlé's nutraceutical resources with EraCal's drug discovery platform. On 3 May 2024, Danone completed its acquisition of Functional Formularies, a US-based whole foods tube feeding business, bolstering its Medical Nutrition portfolio and enteral feeding products.

Key Players

Abbott Laboratories
Ajinomoto Co., Inc.
Baxter International Inc.
Danone S.A
Fresenius Kabi Ltd
Kate Farms
Medifood
Nestlé Health Science
Perrigo Company plc
Reckitt

Ask For Report Customization:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.